TABLE 15.

Matrix of pairwise comparisons on PE/DVT rates in intravenous(mg/kg) administration (shown as odds ratios and 95% confidence intervals)

	10 mg/kg TXA IV	150 mg/kg EACA IV	15 mg/kg TXA IV	20 mg/kg TXA IV	30 mg/kg TXA IV	Placebo
10 mg/kg TXA IV	1	1.48 (0.06, 26.35)	1.01 (0.38, 2.72)	0.86 (0.19, 4.17)	1.35 (0.34, 5.2)	1.13 (0.43, 2.81)
150 mg/kg EACA IV	0.68 (0.04, 15.9)	1	0.68 (0.04, 15.73)	0.58 (0.04, 13.02)	0.89 (0.05, 24.36)	0.75 (0.05, 15.78)
15 mg/kg TXA IV	0.99 (0.37, 2.65)	1.46 (0.06, 23.41)	1	0.86 (0.19, 3.66)	1.34 (0.4, 4.18)	1.12 (0.51, 2.37)
20 mg/kg TXA IV	1.16 (0.24, 5.2)	1.73 (0.08, 27.82)	1.16 (0.27, 5.18)	1	1.58 (0.3, 7.34)	1.3 (0.37, 4.75)
30 mg/kg TXA IV	0.74 (0.19, 2.9)	1.12 (0.04, 18.8)	0.74 (0.24, 2.48)	0.63 (0.14, 3.33)	1	0.83 (0.29, 2.49)
Placebo	0.88 (0.36, 2.33)	1.34 (0.06, 18.63)	0.89 (0.42, 1.95)	0.77 (0.21, 2.7)	1.21 (0.4, 3.43)	1

Abbreviations: IA, intra‐articular; TXA, tranexamic acid; EACA, aminocaproic acid.